Does Anticoagulation in Eisenmenger Syndrome Impact Long-term Survival?

Congenital Heart Disease

Volumn 7, Issue 3, 2012, Pages 268-276

  Sandoval, Julio ^a   Santos, Luis E ^a   Córdova, Julio ^a   Pulido, Tomás ^a   Gutiérrez, Gerardo ^a   Bautista, Edgar ^a   Martinez Guerra, Maria Luisa ^a   Peña, Héctor ^a   Broberg, Craig S ^b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anticoagulation; Cyanosis; Eisenmenger syndrome; Hemoptysis; Pulmonary arterial hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEMOGLOBIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG FATALITY; EISENMENGER COMPLEX; EPISTAXIS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE FAILURE; HEART TAMPONADE; HEMATOTHORAX; HEMATURIA; HEMOPTYSIS; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VAGINA BLEEDING;

ADULT; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; EISENMENGER COMPLEX; HEMORRHAGE; HUMANS; KAPLAN-MEIER ESTIMATE; MEXICO; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861543298     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2012.00633.x     Document Type: Article

References (24)

1. Broberg C, Ujita M, Babu-Narayan S, etal. Massive pulmonary artery thrombosis with haemoptysis in adults with Eisenmenger's syndrome: a clinical dilemma. Heart. 2004;90:e63.
2. Oechslin E. Eisenmenger's syndrome. In: Gatzoulis MA, Webb GD, Daubeney P, eds. Diagnosis and Management of Adult Congenital Heart Disease. Philadelphia, Pa: Churchill Livingstone; 2003:363-377.
3. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation. 2007;115:1039-1050.
4. Bouzas B, Gatzoulis MA. [Pulmonary arterial hypertension in adults with congenital heart disease]. Rev Esp Cardiol. 2005;58:465-469.
5. Galie N, Torbicki A, Barst R, etal. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J. 2004;25:2243-2278.
6. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 1999;99:1858-1865.
7. Galie N, Beghetti M, Gatzoulis MA, etal. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114:48-54.
8. Galie N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:81S-88S.
9. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984;70:580-587.
10. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327:76-81.
11. Frank H, Mlczoch J, Huber K, Schuster E, Gurtner HP, Kneussl M. The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. Chest. 1997;112:714-721.
12. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol. 2003;92:182-187.
13. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol. 2003;42:1982-1987.
14. Broberg CS, Ujita M, Prasad S, etal. Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol. 2007;50:634-642.
15. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. 1958;2:701-709, 755-762.
16. Niwa K, Perloff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol. 1999;34:223-232.
17. Daliento L, Somerville J, Presbitero P, etal. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19:1845-1855.
18. Cantor WJ, Harrison DA, Moussadji JS, etal. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol. 1999;84:677-681.
19. Somerville J. How to manage the Eisenmenger syndrome. Int J Cardiol. 1998;63:1-8.
20. National Committee of Clinical and Laboratory Standards. Collection, transport and processing of blood specimens for testing plasma-based coagulation assays. Approved guideline-fourth addition, 2003: appendix 9.
21. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic congenital heart disease: hematologic management. Ann Intern Med. 1988;109:406-413.
22. Diller GP, Dimopoulos K, Broberg CS, etal. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J. 2006;27:1737-1742. (Epub 2006 Jun 22).
23. Oya H, Nagaya N, Satoh T, etal. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart. 2000;84:53-58.
24. Broberg CS, Bax BE, Okonko DO, etal. Blood viscosity and its relation to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol. 2006;48:356-365.